We sent preliminary examination vote to person targeted for periodical inoculation
We sent preliminary examination vote to person targeted for periodical inoculation in 2022.
Pre-examination votes were sent to eligible students from the 6th grade of elementary school to the 2nd grade of junior high school on June 25, 2022.
It will be shipped to third-year junior high school students and first-year high school students on March 25, 2022.
If you missed the opportunity to receive the regular vaccination and would like to receive it, please see Cervical Cancer Preventive Vaccine (Special Measures).
About inoculation of human papillomavirus (HPV) vaccine
Regarding the HPV vaccine, persistent pain was peculiarly observed after vaccination, for which a causal relationship with the vaccine could not be denied. There was a recommendation from
After that, the Ministry of Health, Labor and Welfare considered the routine vaccination of HPV vaccine, and on November 26, 2021, the recommendation of HPV vaccination was abolished, and the recommendation of individual vaccination was gradually implemented from April, 2022. had.
Those who missed the regular vaccination If you would like to be vaccinated, please see Cervical Cancer Prevention Vaccine (Special Measures).
about diseases
About cervical cancer
Cervical cancer is caused by infection with the oncogenic human papillomavirus (HPV) virus. Cancer that forms at the entrance of the uterus (cervix) in women, and can affect women of all ages. In Japan, about 9,000 people develop the disease and about 2,700 people die each year. It is said
If you suffer from cervical cancer, even if it does not lead to death, there is a possibility that you will have to have a hysterectomy, except for the cancer in the very early stages. It can interfere with daily life.
About human papillomavirus (HPV) infection
Human papillomavirus (HPV) can infect any woman who has had sexual intercourse. In most cases, human papillomavirus (HPV) infection is naturally cleared, but in some cases, infection persists for a long period of time, and in a few cases, the disease persists for years to decades. It develops into cervical cancer through the state of precancerous lesions.
Among the more than 100 genotypes of human papillomavirus (HPV), types 16 and 18 are particularly carcinogenic, and approximately 70% of cervical cancers are caused by HPV types 16 and 18. Infection is believed to be the cause.
In addition, infection with low-risk (non-carcinogenic) types 6, 11, etc. can also cause condyloma acuminata.
About the human papillomavirus (HPV) vaccine
Human papillomavirus (HPV) vaccine does not directly prevent cervical cancer, but causes cervical cancer Vaccines to prevent human papillomavirus infection am.
In inoculation, please judge after understanding the effectiveness and risk.
Persons eligible for routine vaccination
Girls from 6th grade of elementary school to 1st grade of high school
(Vaccinations are available from April 1st for 6th grade elementary school students to March 31st for 1st grade high school students.)
*However, those born between April 2, 2006 and April 1, 2008 can be vaccinated until March 31, 2025 as a special measure even if the above period has passed.
- Special measures for routine inoculation (HPV vaccine) pertaining to human papillomavirus infection
Information/Pre-examination form sending time
Preliminary examination slips will be sent out all at once at the end of March, just before the children enter the 6th grade of elementary school.
inoculation vaccine
There are two types of human papillomavirus (HPV) vaccines: Cervarix (bivalent) and Gardasil (tetravalent).
-
Cervarix (bivalent)
Among the various genotypes of human papillomavirus (HPV), this vaccine contains antigens against types 16 and 18 that are most likely to cause cervical cancer. -
Gardasil (tetravalent)
In addition to type 16 and 18 antigens, which are the main causes of cervical cancer, this vaccine contains type 6 and 11 antigens, which also cause condyloma acuminata and recurrent respiratory papillomatosis.
Number of vaccinations/schedule
3 doses of Cervarix and Gardasil Please note that the vaccination intervals are different.
again, Be sure to inoculate up to 3 times with the same vaccine that you received the first time. Vaccines cannot be changed in the middle.
<Cervarix>
- First time
- 2nd dose 1 month or more after the 1st dose
- 3rd time 6 months or more after the 1st vaccination and 5 months or more after the 2nd vaccination
<Gardasil>
- First time
- 2nd dose: 2 months or more after the 1st dose
- 3rd time 6 months or more after the 1st vaccination and 4 months or more after the 2nd vaccination
*The above intervals are standard. If you are in a hurry, you can complete 3 doses in 5 months for Cervarix and 4 months for Gardasil.
Place of inoculation
Cooperating medical institutions in the ward or cooperating medical institutions contracted with each ward in the 23 wards.
For cooperating medical institutions in Itabashi Ward, please check the following.
In addition, depending on the medical institution, inoculation may require a reservation, so please contact the medical institution in advance.
Inoculation cost
free
Please note that if you miss even one day from the expiration date written on the preliminary examination slip, you will be voluntarily vaccinated (full self-pay).
Required documents
- Cervical Cancer Preventive Vaccination Pre-screening Sheet
- Maternal and Child Health Handbook
- Consent form *For details, please see "Consent form" below.
Please bring
In addition, in case you receive medical treatment for something other than vaccination,
- Health insurance card
- (children's medical certificate)
Please also bring
Consent form
As a general rule, children must be accompanied by a guardian when they are vaccinated.
However, people over the age of 16 can be vaccinated alone without written consent. In addition, regarding vaccinations for children aged 13 and over (after the day before their 13th birthday) and under the age of 16, guardians must understand the effectiveness and risks of vaccines and be convinced that their children are vaccinated. If you wish to have your child vaccinated, you may be vaccinated without a guardian.
At that time, be sure to sign the “Consent Form” and “Self-signed column 1” of the preliminary examination slip, and bring them to the medical institution on the day of vaccination.
Before signing the "Consent Form", please check with your family doctor or Public Health Center Preventive Measures Section in advance about any questions you may have about the vaccination, and only after you fully agree with the vaccination.
Please request the consent form when you apply for the preliminary medical examination form, or download it from the bottom of this page.
Side effects of human papillomavirus infection (cervical cancer prevention) vaccine
Side effects of the bivalent HPV vaccine include local reactions such as pain (99%), redness (88.2%), and swelling (78.8%), and systemic reactions such as mild fever and malaise.
Side effects of the quadrivalent HPV vaccine include local reactions such as pain (82.7%), erythema (32%), and swelling (28.3%), and systemic reactions such as fever and headache.
In rare cases, severe side effects may occur, and the Ministry of Health, Labor and Welfare is currently collecting reports on side effects and having specialists analyze and evaluate them on a regular basis.
For more details, please see human papillomavirus infection (HPV vaccine) (Ministry of Health, Labor and Welfare).
- Consultation counter for those who develop symptoms after being vaccinated against human papillomavirus infection (Ministry of Health, Labor and Welfare) (External link)
Interval between other vaccinations
Human papillomavirus infection (cervical cancer prevention) vaccine is an inactivated vaccine.
If other vaccines are given after the human papillomavirus infection (cervical cancer prevention) vaccination, there is no rule on the interval between vaccinations.
- HPV vaccine leaflet (Ministry of Health, Labor and Welfare) (External link)
- About cervical cancer and HPV vaccine (Ministry of Health, Labor and Welfare) (External link)
- About routine vaccination of HPV vaccine (Tokyo) (External link)
"Adobe® Reader®" is required to view PDF files. If you do not have Adobe website (new window) Download (free) from
Please let us know what you think of the page so that we can improve the website.
About this page inquiry
Health Ikigai Department Preventive Measures Division Vaccination Section 1
〒173-0014 32-15 Oyama Higashimachi, Itabashi-ku, Tokyo Itabashi Public Health Center
Phone: 03-3579-2318 Fax: 03-3579-1337
Please use the dedicated form for inquiries to the Preventive Measures Division, Department of Healthy Ikigai.